The outcome of the cervical cancer (stage Ib1) treated by radical surgery with and without neoadjuvant chemotherapy.
- Author:
Chul Hoi JEONG
;
Jeong Soo KIM
;
Eun Jeoung KANG
;
Kyoung Bok LEE
;
Ki Tae KIM
;
Hyun Chan KIM
- Publication Type:Original Article
- Keywords:
Stage Ib1 Cervical cancer;
Neoadjuvant chemotherapy;
Lymph node metastasis;
stage Ib1
- MeSH:
Drug Therapy*;
Incidence;
Lymph Nodes;
Neoplasm Metastasis;
Recurrence;
Retrospective Studies;
Survival Rate;
Urinary Bladder;
Uterine Cervical Neoplasms*
- From:Korean Journal of Obstetrics and Gynecology
1999;42(11):2570-2575
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
OBJECTIVE: The purpose of this retrospective study was to evaluate the effect of neoadjuvant chemotherapy followed by radical surgery compared with conventional radical surgery in stage Ib1 cervical cancer as to operative complications, the rate of lymph node metastasis, recurrence and overall five-year survival rates. METHODS: The study materal (98 cases of stage Ib1 cervical cancer) was divided into two groups; The one group was neoadjuvant chemotherapy (Cisplatin + 5-FU) followed by radical surgery (n = 41) and the other was the conventional radical surgery (n = 57) group. Reviewing records of operative and pathological reports and clinical findings, the outcome was statistically analyzed and compared. RESULTS: As to the complication, bladder dysfuntion was more frequent in neoadjuvant chemotherapy group, statistically significant.(43.9% vs 22.8%, P=0.034). No significant difference was found in the incidence of lymphnode metastasis (17% vs 17.5%, P=0.779) and overall five year survial rates(85.3% vs 87.7%, P=0.735). CONCLUSION: No benefical effect of neoadjuvant chemotherapy could be found on stage Ib1 cervical cancer in this retrospective study. However, well controlled longterm prospective study will be need to get firm conclusion.
